Raynaud's Phenomenon as Bruton Tyrosine Kinase inhibitor adverse event
Rheumatology (Oxford)
.
2024 Jan 30:keae053.
doi: 10.1093/rheumatology/keae053.
Online ahead of print.
Authors
Dimitrios Deligeorgakis
1
,
Christina Adamichou
1
Affiliation
1
Fourth Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
PMID:
38290781
DOI:
10.1093/rheumatology/keae053
No abstract available